These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 13807568)

  • 1. Some compounds active against experimental visceral leishmaniasis.
    CAPPUCCINO EF; STAUBER LA
    Proc Soc Exp Biol Med; 1959; 101():742-4. PubMed ID: 13807568
    [No Abstract]   [Full Text] [Related]  

  • 2. SOME OBSERVATIONS ON LEISHMANIASIS.
    GRANELLI U
    Dermatol Trop Ecol Geogr; 1964; 35():21-7. PubMed ID: 14165078
    [No Abstract]   [Full Text] [Related]  

  • 3. [The level of antimony in dogs with visceral leishmaniasis treated with solusurmin].
    FUZAILOV IuM
    Med Parazitol (Mosk); 1962; 31():723-7. PubMed ID: 13945955
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of visceral leishmaniasis in children].
    Minodier P; Noël G; Blanc P; Uters M; Retornaz K; Garnier JM
    Med Trop (Mars); 2007 Feb; 67(1):73-8. PubMed ID: 17506279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetoplastid membrane protein-11 DNA vaccination induces complete protection against both pentavalent antimonial-sensitive and -resistant strains of Leishmania donovani that correlates with inducible nitric oxide synthase activity and IL-4 generation: evidence for mixed Th1- and Th2-like responses in visceral leishmaniasis.
    Basu R; Bhaumik S; Basu JM; Naskar K; De T; Roy S
    J Immunol; 2005 Jun; 174(11):7160-71. PubMed ID: 15905560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [METABOLISM OF ANTIMONY IN CHILDREN WITH VISCERAL LEISHMANIASIS TREATED WITH SOLUSURMIN. II].
    FUZAILOV IuM
    Med Parazitol (Mosk); 1964; 33():438-43. PubMed ID: 14250146
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemotherapeutic studies on cutaneous leishmaniosis.
    ERCOLI N
    Proc Soc Exp Biol Med; 1961 Apr; 106():787-90. PubMed ID: 13697061
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparative evaluation of effectiveness of antimony preparations in the treatment of visceral leishmaniasis].
    MIRZOIAN NA
    Med Parazitol (Mosk); 1954; 23(2):161-4. PubMed ID: 13175906
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment options for visceral leishmaniasis: a systematic review of clinical studies done in India, 1980-2004.
    Olliaro PL; Guerin PJ; Gerstl S; Haaskjold AA; Rottingen JA; Sundar S
    Lancet Infect Dis; 2005 Dec; 5(12):763-74. PubMed ID: 16310148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of interferon-gamma in the treatment of visceral and diffuse cutaneous leishmaniasis.
    Badaro R; Johnson WD
    J Infect Dis; 1993 Mar; 167 Suppl 1():S13-7. PubMed ID: 8433014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Syndromes of reduced susceptibility to antimony in visceral leishmaniasis in the child].
    BOIX BARRIOS J; SANCHO PASQUAU V
    Rev Esp Pediatr; 1953; 9(49):41-53. PubMed ID: 13074963
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased thiol levels in antimony-resistant Leishmania infantum isolated from treatment-refractory visceral leishmaniasis in Brazil.
    Magalhães LS; Bomfim LG; Mota SG; Cruz GS; Corrêa CB; Tanajura DM; Lipscomb MW; Borges VM; Jesus AR; Almeida RP; Moura TR
    Mem Inst Oswaldo Cruz; 2018 Feb; 113(2):119-125. PubMed ID: 29236925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma.
    Badaro R; Falcoff E; Badaro FS; Carvalho EM; Pedral-Sampaio D; Barral A; Carvalho JS; Barral-Netto M; Brandely M; Silva L
    N Engl J Med; 1990 Jan; 322(1):16-21. PubMed ID: 2104665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Case of visceral leishmaniasis in adult treated with N-methylglucamine antimony].
    NAPOLITANO F
    G Med Mil; 1952; 102(6):521-7. PubMed ID: 13034080
    [No Abstract]   [Full Text] [Related]  

  • 15. Epiglottis involvement in a visceral leishmaniasis.
    Granel B; Serratrice J; Christides C; Richard-Vitton T; Minodier P; Horshowski N; Disdier P; Thomassin JM; Weiller PJ
    J Infect; 2002 Oct; 45(3):196-7. PubMed ID: 12387777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Visceral leishmaniasis: ultrastructural findings in the bone marrow cells].
    Inferrera C; Princi P
    Arch De Vecchi Anat Patol; 1967 Oct; 49(3):757-75. PubMed ID: 5606008
    [No Abstract]   [Full Text] [Related]  

  • 17. Asiaticoside induces tumour-necrosis-factor-α-mediated nitric oxide production to cure experimental visceral leishmaniasis caused by antimony-susceptible and -resistant Leishmania donovani strains.
    Bhaumik SK; Paul J; Naskar K; Karmakar S; De T
    J Antimicrob Chemother; 2012 Apr; 67(4):910-20. PubMed ID: 22258930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [CONTRIBUTION TO THE KNOWLEDGE OF VISCERAL LEISHMANIASIS OF THE ADULT].
    DEGREGORIO G; QUATTROCCHI G
    Riforma Med; 1963 Nov; 77():1278-81. PubMed ID: 14125697
    [No Abstract]   [Full Text] [Related]  

  • 19. Amphotericin B lipid complex in the management of antimony unresponsive Indian visceral leishmaniasis.
    Sundar S; Goyal AK; Mandal AK; Makharia MK; Singh VP; Murray HW
    J Assoc Physicians India; 1999 Feb; 47(2):186-8. PubMed ID: 10999086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [N-methylglucamine antimoniate in the treatment of visceral leishmaniasis; first cases treated in Spain].
    BOIX BARRIOS J
    Rev Cubana Pediatr; 1952 Jul; 24(7):433-42. PubMed ID: 12994219
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.